These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1345741)

  • 1. Blood-brain barrier changes in multiple sclerosis.
    Trojano M; Manzari C; Livrea P
    Ital J Neurol Sci; 1992 Dec; 13(9 Suppl 14):55-64. PubMed ID: 1345741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting.
    Correale J; Villa A
    Autoimmunity; 2007 Mar; 40(2):148-60. PubMed ID: 17453713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does damage of perivascular astrocytes in multiple sclerosis plaques participate in blood-brain barrier permeability?
    Rafałowska J; Krajewski S; Dolińska E; Dziewulska D
    Neuropatol Pol; 1992; 30(1):73-80. PubMed ID: 1484610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The blood-brain barrier in cortical multiple sclerosis lesions.
    van Horssen J; Brink BP; de Vries HE; van der Valk P; Bø L
    J Neuropathol Exp Neurol; 2007 Apr; 66(4):321-8. PubMed ID: 17413323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of blood-brain barrier disruption on glial cell function in multiple sclerosis.
    McQuaid S; Cunnea P; McMahon J; Fitzgerald U
    Biochem Soc Trans; 2009 Feb; 37(Pt 1):329-31. PubMed ID: 19143657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis.
    Ifergan I; Wosik K; Cayrol R; Kébir H; Auger C; Bernard M; Bouthillier A; Moumdjian R; Duquette P; Prat A
    Ann Neurol; 2006 Jul; 60(1):45-55. PubMed ID: 16729291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
    Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H
    Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How do immune cells overcome the blood-brain barrier in multiple sclerosis?
    Larochelle C; Alvarez JI; Prat A
    FEBS Lett; 2011 Dec; 585(23):3770-80. PubMed ID: 21550344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blood-brain barrier in multiple sclerosis: mechanisms of its breakdown and repair].
    Kanda T
    Nihon Rinsho; 2003 Aug; 61(8):1402-8. PubMed ID: 12962030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The blood-brain barrier (BBB) permeability in multiple sclerosis.
    Rafałowska J; Krajewski S; Dolińska E
    Neuropatol Pol; 1990; 28(1-2):41-54. PubMed ID: 2097537
    [No Abstract]   [Full Text] [Related]  

  • 11. [Endothelial cell activation and/or injury in multiple sclerosis: analysis with von Willebrand factor and thrombomodulin].
    Kohriyama T; Maruyama H; Kurokawa K; Harada T; Nakamura S
    Rinsho Shinkeigaku; 1997 Apr; 37(4):287-91. PubMed ID: 9248336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathology of multiple sclerosis.
    Sobel RA
    Neurol Clin; 1995 Feb; 13(1):1-21. PubMed ID: 7739499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the role of interleukin-2 (IL-2) in multiple sclerosis (MS). IL-2-mediated endothelial cell activation.
    Gallo P; Pagni S; Piccinno MG; Giometto B; Argentiero V; Chiusole M; Bozza F; Tavolato B
    Ital J Neurol Sci; 1992 Dec; 13(9 Suppl 14):65-8. PubMed ID: 1345742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases.
    Stolp HB; Dziegielewska KM
    Neuropathol Appl Neurobiol; 2009 Apr; 35(2):132-46. PubMed ID: 19077110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli.
    Silwedel C; Förster C
    J Neuroimmunol; 2006 Oct; 179(1-2):37-45. PubMed ID: 16884785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
    Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
    Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infiltration of inflammatory cells through brain endothelium.
    Couraud PO
    Pathol Biol (Paris); 1998 Mar; 46(3):176-80. PubMed ID: 9769913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of the blood-brain barrier.
    Engelhardt B
    Cell Tissue Res; 2003 Oct; 314(1):119-29. PubMed ID: 12955493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
    Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunopathogenesis of multiple sclerosis.
    Agrawal SM; Yong VW
    Int Rev Neurobiol; 2007; 79():99-126. PubMed ID: 17531839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.